Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
RANDOX LABORATORIES

Events

10 Oct 2016 - 12 Oct 2016
12 Nov 2016 - 16 Nov 2016

Brown Fat Research Advances with a Ground-Breaking MRI Scan

By BiotechDaily International staff writers
Posted on 05 May 2014
Print article
Image: The first MRI scan to show “brown fat” in a living adult could prove to be an essential step towards a new wave of therapies to aid the fight against diabetes and obesity (Photo courtesy of Warwick Medical School).
Image: The first MRI scan to show “brown fat” in a living adult could prove to be an essential step towards a new wave of therapies to aid the fight against diabetes and obesity (Photo courtesy of Warwick Medical School).
A magnetic resonance imaging (MRI) scan is the first to show “brown fat” in a living adult, and could provide vital information for new treatments to aid the fight against diabetes and obesity.

Researchers from Warwick University Medical School (Coventry, UK) and University Hospitals Coventry (UK) and Warwickshire NHS [National Health Service] Trust used MRI-based technology to identify and validate the presence of brown adipose tissue in a living adult.

Brown fat has become a heated subject for scientists because its ability to use energy and burn calories, helping to keep weight in check. Understanding the brown fat tissue and how it can be utilized is of growing interest in the search to help obese individuals or at a high risk of developing diabetes.

Dr. Thomas Barber, from the department of metabolic and vascular health at Warwick Medical School, explained, “This is an exciting area of study that requires further research and discovery. The potential is there for us to develop safe and effective ways of activating this brown fat to promote weight loss and increase energy expenditure--but we need more data to be able to get to that point. This particular proof of concept is key, as it allows us to pursue MRI techniques in future assessments and gather this required information.”

The study published January 2014 in the Journal of Clinical Endocrinology and Metabolism described the advantages of using MRI scans over the existing method of positron emission tomography (PET). While PET imaging reveals brown fat activity, it is subject to a range of limitations including the challenge of signal variability from a changing environmental temperature.

In contrast to the PET data, which only displays activity, MRI can show brown fat content whether active or not, providing a detailed insight into where it can be found in the adult body. These data could become vital in the development of future therapies that seek to activate deposits of brown fat.

Dr. Barber added, “The MRI allows us to distinguish between the brown fat, and the more well-known white fat that people associate with weight gain, due to the different water to fat ratio of the two tissue types. We can use the scans to highlight what we term ‘regions of interest’ that can help us to build a picture of where the brown fat is located.”

With the proof of concept study now completed, the next phase of research is to further corroborate this technique across a larger group of adults.

Related Links:

Warwick University Medical School
University Hospitals Coventry



Print article

Channels

Drug Discovery

view channel
Image: Ginger is the source of a novel class of nanolipid transport vector (Photo courtesy of Georgia State University).

Ginger-Derived Doxorubicin-Loaded Nanovectors as Drug Delivery for Cancer Therapy

A novel type of nanoparticle drug transport system based on lipids isolated from ginger was used to deliver the toxic chemotherapeutic agent doxorubicin (Dox) to colon cancer cells with minimal damage... Read more

Biochemistry

view channel
Image: A space-filling model of the anticonvulsant drug carbamazepine (Photo courtesy of Wikimedia Commons).

Wastewater May Contaminate Crops with Potentially Dangerous Pharmaceuticals

Reclaimed wastewater used to irrigate crops is contaminated with pharmaceutical residues that can be detected in the urine of those who consumed such produce. Investigators at the Hebrew University... Read more

Business

view channel

Collaborative Agreement to Aid in Setting Guidelines for Evaluating Potential Ebola Therapy

Cooperation between an Israeli biopharmaceutical company and medical branches of the US government is designed to set ground rules for continued evaluation of an experimental therapy for Ebola virus disease. RedHill Biopharma Ltd. (Tel Aviv, Israel), a biopharmaceutical company primarily focused on development and c... Read more
Copyright © 2000-2016 Globetech Media. All rights reserved.